Updates‎ > ‎

Brain Tumor 2017 Berlin Meeting

posted May 24, 2017, 7:07 AM by Kacper Walentynowicz   [ updated May 30, 2017, 12:51 AM ]


Our lab has visited our collaborators in Berlin at the The Max Delbrück Center for Molecular Medicine to attend the Brain Tumor Meeting 2017.

At the conference, we had a chance to present our recent data on minocycline and its potential therapeutic effect in rat glioma model. The presentation was given by Dr Anna Gieryng who leads the project on potential minocycline therapy.

We were also selected to present 4 posters at the poster session that included many researchers from around the world.
Posters were presented by:
* Dr Iwona Ciechomska 'Exploring glioma heterogeneity using immunoblotting and immunohistochemistry.'
* Dr Aleksandra Ellert-Miklaszewska 'Expression and function of NFAT nuclear factor of activated T cells transcription factors in human gliomas.'
* Karolina Stępniak 'Open chromatin and epigenetic landscape of human benign and malignant gliomas.'
* Bartłomiej Gielniewski 'The impact of IDH1/2 mutations on SOCS gene methylation and deregulation of STAT signalling in gliomas.'